Marex (MRX) Cash & Equivalents (2022 - 2026)

Marex has reported Cash & Equivalents for 5 years, with the latest figure at $3.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 17.73% year-over-year to $3.1 billion; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (up 17.73% YoY), and the FY2025 full-year result was $2.9 billion, up 12.7% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $3.1 billion, up from $2.9 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $3.4 billion in Q2 2025, with the low at $910.1 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $2.4 billion across 5 years, with a median of $2.6 billion in 2025.
• The largest YoY upside for Cash & Equivalents was 76.33% in 2025 against a maximum downside of 12.7% in 2025.
• Marex's Cash & Equivalents stood at $910.1 million in 2022, then soared by 63.0% to $1.5 billion in 2023, then soared by 72.34% to $2.6 billion in 2024, then gained by 12.7% to $2.9 billion in 2025, then gained by 6.51% to $3.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.1 billion (Q1 2026), $2.9 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.